Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study.

BACKGROUND: Type 2 diabetes poses an increasing disease burden in South Korea. The development and management of type 2 diabetes are closely related to lifestyle and socioeconomic factors, which have undergone substantial changes over the past few decades, including during the COVID-19 pandemic. OBJECTIVE: This study aimed to investigate long-term trends in type 2 diabetes prevalence, awareness, treatment, and control. It also aimed to determine whether there were substantial alterations in the trends during the pandemic and whether these changes were more pronounced within specific demographic groups. METHODS: This study examined the prevalence, awareness, treatment, and control of type 2 diabetes in a representative sample of 139,786 South Koreans aged >30 years, using data from the National Health and Nutrition Examination Survey and covering the period from 1998 to 2022. Weighted linear regression and binary logistic regression were performed to calculate weighted ß coefficients or odds ratios. Stratified analyses were performed based on sex, age, region of residence, obesity status, educational background, household income, and smoking status. ß (difference) was calculated to analyze the trend difference between the prepandemic period and the COVID-19 pandemic. To identify groups more susceptible to type 2 diabetes, we estimated interaction terms for each factor and calculated weighted odds ratios. RESULTS: From 1998 to 2022, a consistent increase in the prevalence of type 2 diabetes was observed among South Koreans, with a notable rise to 15.61% (95% CI 14.83-16.38) during the pandemic. Awareness followed a U-shaped curve, bottoming out at 64.37% (95% CI 61.79-66.96) from 2013 to 2015 before increasing to 72.56% (95% CI 70.39-74.72) during the pandemic. Treatment also increased over time, peaking at 68.33% (95% CI 65.95-70.71) during the pandemic. Control among participants with diabetes showed no substantial change, maintaining a rate of 29.14% (95% CI 26.82-31.47) from 2020 to 2022, while control among treated participants improved to 30.68% (95% CI 27.88-33.48). During the pandemic, there was a steepening of the curves for awareness and treatment. However, while the slope of control among participants being treated increased, the slope of control among participants with diabetes showed no substantial change during the pandemic. Older populations and individuals with lower educational level exhibited less improvement in awareness and control trends than younger populations and more educated individuals. People with lower income experienced a deceleration in prevalence during the pandemic. CONCLUSIONS: Over the recent decade, there has been an increase in type 2 diabetes prevalence, awareness, treatment, and control. During the pandemic, a steeper increase in awareness, treatment, and control among participants being treated was observed. However, there were heterogeneous changes across different population groups, underscoring the need for targeted interventions to address disparities and improve diabetes management for susceptible populations.

Establishment of Biomimetic Soft Tissue Integration with the Surface of Zirconia Fused with Platelet-Activating Peptide.

Soft tissue sealing around zirconia (ZrO2) abutment is critical for the long-term stability of dental implants. The goal of the study is to develop a strong basal lamina (BL)-mediated epithelial attachment to ZrO2 via a novel physicochemical immobilization method. An electrophoretic fusion (EPF) method was applied to fuse a phosphonic acid (PA) linker to ZrO2 discs. Bindings of the PA linker and the following protease activated receptor 4 (PAR4) were verified by Fourier-transform infrared spectroscopy (FITR). Then, ZrO2 discs were doped in platelet-rich plasma (PRP). Platelet-derived growth factor (PDGF) was measured to assess platelet activation. PRP-doped discs were subsequently co-cultured with human gingival epithelial cells (OBA9) to evaluate establishment of basal lamina-mediated epithelial attachment. The EPF method achieved robust immobilization of the PA linker and PAR4 onto the ZrO2 surface. The resultant PAR4-coupled ZrO2 successfully induced platelet aggregation and activation. Furthermore, a BL-mediated epithelial attachment was established. The results are significant for clinical application to minimize the risk of developing peri-implant diseases.

Evaluation of an Innovative Hybrid Macrogeometry Dental Implant in Immediate Extraction Sockets: A Histomorphometric Pilot Study in Foxhound Dogs.

A preclinical pilot study was performed to evaluate the safety, efficacy, primary stability, and wound healing of a hybrid dental implant with a unique macrogeometry design in which the coronal section is narrower and cylinder-shaped followed by a wider, tapered apical portion, each comprising approximately one half the length of the implant. Eighteen hybrid macrogeometry-designed dental implants were placed bilaterally into three foxhounds in the mandibular third and fourth premolar and first molar (P3, P4, and M1, respectively) extraction sockets of different dimensions immediately following full periosteal flap elevation and removal of teeth without socket grafting. Bone plate thickness, implant position and depth, gap distance, and insertion torque values were measured following implant installation. Surgical sites were healed uneventfully for 3 months, and then samples of soft and hard tissues surrounding the implants were retrieved to perform light microscopic and histomorphometric analyses. All 18 implants were stable and osseointegrated both clinically and radiographically. The analyses revealed that the amount of hard tissue alteration and bone fill that occurred during the healing period was significantly influenced by the thickness of the bone plate, the size of the horizontal buccal gap, and the implant diameter, position, and depth within the extraction socket. The P3 and P4 hybrid implants placed approximately 1.0 mm subcrestal from the interproximal height of bone with less gap distance (≤ 1.0 mm) exhibited minor to modest (1.5 to 2.0 mm) crestal bone remodeling relative to the implant platform. Conversely, M1 implants positioned with greater depth (≥ 2.0 mm) and gap distance (≥ 2.0 mm) that were evaluated in a buccal-lingual dimension exhibited minimal crestal change with first bone-to-implant contact within 1.0 mm (range: 0.00 to 0.89 mm) of the machined-collar surface. The thicker lingual bone plate on all M1 implants was relatively maintained and unaffected. The apical half of the implant provided high initial stability (range: 65 to 100 Ncm). The mean percentage of bone-to-implant contact was 56.34% (range: 40.15% to 72.04%). This preclinical study provided clinical and histologic evidence to support the safety and efficacy of a new hybrid macrogeometry implant design that achieved excellent primary and secondary stability in immediate extraction sockets without grafting.